Memantine induces heat shock protein HSP70 in the posterior cingulate cortex, retrosplenial cortex and dentate gyrus of rat brain

Brain Research

Volumn 740, Issue 1-2, 1996, Pages 1-5

  Tomitaka, S ^a,b   Hashimoto, K ^a   Narita, N ^a   Sakamoto, A ^c   Minabe, Y ^a   Tamura, A ^b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Toyama Medical and Pharmaceutical University   (Japan)

Author keywords

AIDS dementia complex; amantadine; heat shock protein; memantine; N methyl D aspartate receptor

Indexed keywords

AMANTADINE; DIZOCILPINE; HEAT SHOCK PROTEIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; DENTATE GYRUS; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; DENTATE GYRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GYRUS CINGULI; HSP70 HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; KETAMINE; MALE; MEMANTINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030592742     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00842-6     Document Type: Article

References (25)

1. [1] Bormann, J., Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels, Eur. J. Phamacol., 166 (1989) 591-592.
2. [2] Bubser, M., Kesenberg, U., Notz, P.K. and Schmidt, W.J., Differential behavioral and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats, Eur. J. Pharmacol., 229 (1992) 75-82.
3. [3] Chen, H.-S.V., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E. and Lipton, S.A., Open-channel block of N-methyl-D-aspartate responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotosicity, J. Neurosci., 12 (1992) 4427-4436.
4. [4] Erdö, S.L. and Schäfer, M., Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate, Eur. J. Pharmacol., 198 (1991) 215-217.
5. [5] Hashimoto, K., Tomitaka, S., Narita, N., Minabe, Y., Iyo, M. and Fukui, S., Induction of heat shock protein HSP70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine. Addiction Biol., 1 (1996) 61-70.
6. [6] Keilhoff, G. and Wolf, G., Memantine prevents quinolinic acid-induced hippocampal damage, Eur. J. Phamacol., 219 (1992) 451-454.
7. 3H]MK801 at therapeutic concentrations in postmortem human frontal cortex, Eur. J. Pharmacol., 166 (1989) 589-590.
8. [8] Kornhuber, J., Weller, M., Schoppmeyer, K. and Riederer, P., Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties, J. Neurol. Transm. Suppl., 43 (1994) 91-104.
9. [9] Lipton, S.A. and Rosenburg, P.A., Excitatory amino acids as a final common pathway for neurologic disorders, N. Engl. J. Med., 330 (1994) 613-622.
10. [10] Olney, J.W., Labruyere, J. and Price, M.T., Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science, 244 (1989) 1360-1362.
11. [11] Olney, J.W., Labruyere, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: mechanism and prevention, Science, 254 (1991) 1515-1518.
12. [12] Park, C.K., Nehls, D.G., Graham, D.I., Teasdale, G.M. and McCulloch, J., The glutamate antagonist MK-801 reduces focal ischemic damage in the rat, Ann. Neurol, 24 (1988) 543-551.
13. [13] Parsons, C.G., Gruner, R., Rozental, J., Millar, J. and Lodge, D., Patch clamp studies on the kinetic and selectivity of N-methyl-D-aspartate receptor antagonism by memantine, Neuropharmacology, 32 (1993) 1337-1350.
14. [14] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1988.
15. [15] Porter, R.H.P. and Greenamyre, J.T., Regional variations in the pharmacology of NMDA receptor channel blockers: Implications for therapeutic potential, J. Neurochem., 64 (1995) 614-623.
16. [16] Rabey, J.M., Nissipeanu, P. and Korczyn, A.D., Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease, J. Neural. Transm. P-D. Sect., 4 (1992) 277-282.
17. [17] Rogawski, M.A., Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci., 14 (1993) 325-331.
18. [18] Seif el Nasar, M., Perucher, B., Rosseberg, C., Mennel, H.-D. and Krieglstein, J., Neuroprotective effect of memantine demonstrated in vivo and in vitro, Eur. J. Pharmacol, 185 (1990) 19-24.
19. [19] Sharp, F.R., Jasper, P., Hall, J., Nobel, L. and Sagar, S.M., MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior and retrosplenial cortex, Ann. Neurol., 30 (1991) 801-809.
20. [20] Sharp, F.R., Butman, M., Wang, S., Koistinaho, J., Graham S.H., Sagar, S.M., Noble, L., Berger, P. and Longo, F.M., Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine, MK801, and Ketamine. J. Neurosci. Res., 33 (1992) 605-616.
21. [21] Sharp, F.R., Butman, M., Koistinaho, J., Aardalen, K., Nakki, R., Massa, S.M., Swanson, R.A. and Sagar, S.M., Phencyclidine induction of the hsp70 gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels, Neuroscience, 62 (1994) 1079-1092.
22. [22] Starr, M.S. and Starr, B.S., Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist, J. Neural. Transm. P-D. Sect., 9 (1995) 31-43.
23. [23] Toggas, S.M., Marsliah, E. and Mucke, L., Prevention of HIV-1 gp 120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine, Brain Res., 706 (1996) 303-307.
24. [24] Tomitaka, S., Hashimoto, K., Narita, N., Minabe, Y. and Tamura, A., Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists, Eur. J. Pharmacol., 285 (1995) 207-211.
25. [25] Von Voigtlander, P.F. and Moore, K.E., Dopamine release from the brain in vivo by amantadine, Science, 174 (1971) 408-410.